Related Experiment Videos
Update on immunopathogenesis in inflammatory myopathies
1Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. knagaraj@mail.jhmi.edu
Current Opinion in Rheumatology
|November 8, 2001
Summary
Myositis involves autoimmune responses with specific autoantibodies and T cells. Understanding skeletal muscle cell interactions offers new therapeutic targets and insights into gene therapy.
Area of Science:
- Immunology
- Autoimmune Diseases
- Skeletal Muscle Biology
Background:
- Myositis is characterized by autoimmune processes, evidenced by myositis-specific autoantibodies and autoreactive T cells.
- Recent research indicates active cell-cell interactions in myositis, with upregulated immune molecules.
- Skeletal muscle cells' role in immune responses is increasingly recognized due to emerging therapies.
Purpose of the Study:
- To explore the immunologic capabilities of skeletal muscle cells.
- To identify potential novel therapeutic targets for myositis.
- To understand the contribution of skeletal muscle to autoimmune mechanisms and gene therapy.
Main Methods:
- Analysis of immunological markers in myositis patients.
- Investigation of cell-cell interactions involving skeletal muscle cells.
- Review of current and emerging therapeutic strategies.
Main Results:
- Evidence of autoimmune involvement in myositis through autoantibodies and T cells.
- Upregulation of immune molecules suggests active cellular crosstalk.
- Skeletal muscle cells possess immunologic functions relevant to disease and therapy.
Conclusions:
- Understanding skeletal muscle immunobiology is crucial for myositis treatment.
- Novel therapeutic strategies may target cell-cell interactions in myositis.
- Skeletal muscle serves as a potential site for transgene expression in gene therapy.